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Short Report Autoimmune thyroiditis in antinuclear antibody 
positive children without rheumatologic disease
KathrynSTorok*1 and Thaschawee Arkachaisri2,3
Abstract
Background: Children are commonly referred to a pediatric rheumatology center for the laboratory finding of an Anti-
nuclear antibody (ANA) of undetermined significance. Previous studies regarding adult rheumatology patients have 
supported an association between ANA and anti-thyroid antibodies, with the prevalence of thyroid antibodies being 
significantly higher in patients referred to a rheumatology center for an ANA without evidence of connective tissue 
disease compared to the general population. The purpose of the present study was to determine the frequency of 
thyroid antibodies in children referred to a pediatric rheumatology center for a positive ANA without evidence of a 
connective tissue disease.
Methods: A retrospective chart review was performed on children who were referred to our pediatric rheumatology 
center between August 2003 and March 2007 for positive ANA with concurrent thyroid antibody and thyroid function 
tests performed who did not fulfill criteria for a specific connective tissue disease. Laboratory and clinical features were 
recorded and analyzed. Mean and standard deviation were used to describe continuous data. Chi-square or Fisher's 
exact tests were used to compare proportions between variables.
Results: One-hundred and four ANA-positive patients with concurrent thyroid studies were evaluated (88% female, 
93% Caucasian, mean age 11.9 ± 4.0 years). Half of patients had an ANA titer ≥ 1:320. The ANA pattern was speckled in 
60% of the patients. Thyroid antibodies were detected in 30% of the patients. Anti-Thyroglobulin (ATG) was detected in 
29% and Anti-thyroid peroxidase (ATPO) in 21% of the patients; of these children, 14% had hypothyroidism. ANA 
pattern and titer were not associated with anti-thyroid antibody positivity.
Conclusion: Thyroid antibodies associated with chronic lymphocytic thyroiditis, ATG and ATPO, were detected 
significantly higher in ANA-positive children without a rheumatologic condition (30%) as compared to the general 
pediatric population (1.3 - 3.4%). ANA titer and pattern did not help predict the presence or absence of thyroid 
antibodies. Given the high frequency of thyroid antibodies and increased risk of developing hypothyroidism over time, 
routine evaluation of ATG and ATPO with thyroid function tests in ANA-positive children is recommended.
Background
Approximately 20% of new patients seen at pediatric
rheumatology centers are referrals for ANA positivity
[1,2]. Of these, 27 to 73%, do not have an underlying con-
nective tissue disease (CTD). General practitioners com-
monly send an ANA in a child with non-specific
musculoskeletal complaints, such as myalgia and arthral-
gia. The clinical meaning of a positive ANA in a child
with nonspecific musculoskeletal complaints without evi-
dence of an autoimmune diagnosis has been a debated
issue [1-3]. Several studies have followed these children
overtime (3 to 5 years) and overall, they do not develop a
CTD, regardless of ANA titer or pattern [1,2].
ANA has been detected in other non-CTD autoim-
mune diseases, such as autoimmune thyroiditis (also
termed chronic lymphocytic thyroiditis or Hashimoto's
thyroiditis). The frequency of ANA positivity in children
with autoimmune thyroiditis has been reported in the
range of 30% to 70% [4]. Possible theories for the high
association of ANA with autoimmune thyroiditis are
enhanced apoptosis of thyroid follicular cells, exposing
nuclear antigens to elicit development of ANA, and B cell
hyperactivity with production of multiple autoantibodies
[5,6].
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Autoimmune thyroiditis is the most common autoim-
mune disease in all ages, with a prevalence of 1.3 - 3.4% in
children, depending on geographic location, type of study
and gender of patients [7-11]. Despite the prevalence of
autoimmune thyroiditis in the general population and its
association with ANA, the frequency of autoimmune thy-
roiditis in the presence of ANA in a child without a
known autoimmune disease has not been reported. Auto-
immune thyroiditis, or Hashimoto's thyroiditis, can be
identified by the presence of Anti-Thyroglobulin [ATG]
a n d / o r  A n t i - T h y r o i d  P e r o x i d a s e  [ A T P O ]  a n t i b o d i e s  i n
the serum with or without thyroid hormone abnormali-
ties (in a euthyroid state) or clinical symptoms [7]. In our
clinical experience, we have noticed an association
between ANA positivity and thyroid antibody positivity
in patients without a known autoimmune disease; how-
ever, this phenomenon has not been officially studied in a
pediatric population. Therefore, this study was designed
to addresses the prevalence of thyroid antibody positivity
(Anti-Thyroglobulin [ATG] and/or Anti-Thyroid Peroxi-
dase [ATPO] antibodies) in ANA positive children with-
out a CTD.
Patients and Methods
The University of Pittsburgh's Institutional Review Board
approved the study prior to data retrieval. All patients
younger than 18 years of age who were referred to our
pediatric rheumatology center between August 2003 and
March 2007 for a positive ANA with concurrent thyroid
antibodies (ATG and ATPO) and thyroid function studies
(TSH and FT4), and who did not fulfill criteria for a spe-
cific connective tissue disease or autoimmune disease
were included. Patients with known thyroid disease were
excluded.
Laboratory evaluation
ANA was identified by HEp-2 cells, indirect immunofluo-
rescence technique. A titer of 1:40 or higher was consid-
ered positive. ATG and ATPO were detected by ELISA,
both with the cut-off level of < 60 International Units/ml
for normal. TSH and FT4  were evaluated using age
adjusted normal levels.
Statistical analysis
Mean and standard deviation were used to describe con-
tinuous data. Chi-square or Fisher's exact tests were used
to compare proportions between variables with a p-value
< 0.05 considered as significant.
Results
Two-hundred and thirty-eight patients were referred for
a positive ANA and were judged not to have an underly-
ing connective tissue disease by a pediatric rheumatolo-
gist from August 2003 to March 2007. Of these patients,
104 had thyroid antibodies (ATG and ATPO) and thyroid
function studies (TSH and FT4) evaluated. The demo-
graphic, clinical and laboratory features of these 104
patients are displayed in Table 1. Ninety-three percent
were Caucasian, 88% were female, and the mean age was
11.9 ± 4.0 years. Arthralgia was the most common com-
plaint (52%). Positive thyroid antibodies were found in
31/104 (30%) of the patients. ATG was detected in 29%
(30/104), ATPO in 21% (22/104) of the patients, and both
antibodies were positive in 68% (21/31) of the anti-body
positive patients. Ninety six percent of ATG-positive
patients also produced ATPO, and 70% of ATPO-patients
produced ATG.
There was no statistically significant difference
between the positive thyroid antibody group (n = 31) and
the negative thyroid antibody group (n = 73) in regard to
age at initial evaluation, ethnicity, gender or family his-
tory of autoimmune disease. Further analysis of age of
onset, by using > 8 years old as an arbitrary cut-off, dem-
onstrated that the proportion of children > 8 years old in
the positive thyroid antibody group was marginally sig-
nificantly higher (p = 0.06) than those in the negative thy-
roid antibody group (90% vs. 73% respectively); analysis
not shown. Of note clinically is the higher proportion of
females with positive thyroid antibodies compared to
males, 33% (30/91) vs. 8% (1/13) respectively. Also dem-
onstrated, though not significant, is a higher proportion
of those in the positive thyroid antibody group with a
family history of autoimmune disease compared to the
negative thyroid antibody group, 61% vs. 48% respec-
tively. The most common familial autoimmune disease in
both groups was autoimmune thyroiditis, followed by
rheumatoid arthritis and insulin-dependent diabetes mel-
litus. ANA titer and pattern did not associate with the
presence of thyroid antibodies. Both groups had approxi-
mately half of the patients with a titer ≥ 320, and the pat-
tern was speckled in 60% of all patients (Table 1).
The majority of the thyroid antibody positive patients
were in euthyroid state; however, 14% had hypothyroid-
ism requiring therapy (3 at the initial visit and 1 during
follow-up). Mean duration of follow-up was 4.6 ± 9.3
months.
Discussion
One third of the patients referred to our pediatric rheu-
matology center for a positive ANA without fulfilling
diagnosis of CTD with concurrent evaluation of thyroid
antibodies and thyroid function were found to have posi-
tive thyroid antibodies, ATG and ATPO, indicating auto-
immune thyroiditis (or Hashimoto's thyroiditis). This is 7
times more frequent than the prevalence of ATG and
ATPO reported in the healthy pediatric population inter-
nationally, 1.3 - 3.4% [7-11]. Therefore, our practice of
screening for clinically silent autoimmune thyroiditis inTorok and Arkachaisri Pediatric Rheumatology 2010, 8:15
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ANA positive children is substantiated by the increased
proportion of thyroid antibodies in these children, with
potential to evolve into hypothyroidism. Older age,
female gender, and family history of autoimmune disease,
though not statistically significant, should raise a higher
suspicion for inspection of these antibodies in the pres-
ence of a positive ANA. Although not analyzed in this
study due to the retrospective design and lower preva-
lence of Grave's disease in the pediatric population
(0.04%) [11], anti-TSH receptor antibodies should also be
considered, as they are also associated with ANA positiv-
ity [5,6], but are typically identified in patients that
already have clinical signs and symptoms of hyperthy-
roidism.
The frequency of ATG and ATPO detected in the pres-
ence of an ANA of unknown cause in adults referred to
rheumatologists was reported to be 10 - 16%, which is
lower than the frequency we reported here in children
[12-14]. Hypothyroidism developed in the majority of
these patients, 40 - 60%, within 2 years [12-14]. In chil-
dren with autoimmune thyroiditis, hypothyroidism even-
tually developed in 20 - 50% within 5 years [7-11].
Fourteen percent of the 31 thyroid antibody-positive
patients in our study developed hypothyroidism requir-
ing therapy within our limited follow-up time (mean of 5
months). The annual incidence of a euthyroid child
becoming hypothyroid in the presence of thyroid anti-
bodies, ATG or ATPO, is 2 - 3% [10]. Proper identifica-
tion of these patients is necessary for early and
appropriate management.
In conclusion, we found one-third of non-CTD, ANA-
positive children to have positive anti-thyroid antibodies
associated with autoimmune thyroiditis, ATG and ATPO.
Based on these findings and given the increased cumula-
tive risk of euthyroid autoimmune thyroiditis in children
evolving into overt thyroid disease, we recommend rou-
tine screening of anti-thyroid antibodies, ATG and
ATPO, and thyroid function tests, TSH and FT4, in chil-
dren with a positive ANA.
List of Abbreviations
ANA: Anti-nuclear antibody; ATG: Anti-thyroglobulin;
ATPO: Anti-thyroid peroxidase; CTD: Connective tissue
Table 1: Demographic Data, Laboratory and Clinical Features
Positive Thyroid Antibodies
(n = 31)
Negative Thyroid 
Antibodies
(n = 73)
Total
(n = 104)
Demographic features
Female (% within group) 30 (97) 61 (84) 91 (88)
Caucasian (%) 29 (94) 68 (93) 97 (93)
Age at first visit (yr) ± SD 12.9 ± 3.1 11.6 ± 4.2 11.9 ± 4.0
Family history autoimmune disease†
1st degree relative (%) 11 (35) 14 (19) 25 (24)
1st or 2nd degree relative (%) 19 (61) 35 (48) 54 (52)
ANA pattern
Homogenous (%) 13 (42) 25 (34) 38 (37)
Speckled (%) 17 (55) 45 (62) 62 (60)
Nucleolar (%) 1 (3) 2 (3) 3 (3)
Clinical manifestations
Arthralgia (%) 10 (32) 44 (60) 54 (52)
Rash (%) 3 (10) 9 (12) 12 (11)
Vitiligo (%) 4 (13) 2 (3) 6 (6)
Alopecia (%) 3 (10) 2 (3) 5 (5)
Fatigue (%) 2 (6) 6 (8) 8 (8)
Miscellaneous‡ (%) 9 (29) 10 (14) 19 (18)
* none of the calculated p-values < 0.05
†Autoimmune diseases include: autoimmune thryoiditis (Hashimoto's thyroiditis), Grave's disease, rheumatoid arthritis, insulin-dependent 
diabetes mellitus, ulcerative colitis, Crohn's disease, systemic lupus erythematosus, psoriasis, multiple sclerosis
‡ Miscellaneous manifestations include: myalgia, urticaria, thrombocytopenia, acrocyanosisTorok and Arkachaisri Pediatric Rheumatology 2010, 8:15
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disease; TSH: thyroid-stimulating hormone; FT4: free
serum thyroxine.
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